GE Healthcare and Bio-Rad reach settlement in label-free detection lawsuit

Chalfont St.Giles, UK, August 13th, 2011 – GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today that a settlement has been reached with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) in an intellectual property lawsuit related to GE Healthcare Life Sciences’...

GE Healthcare and Bio-Rad reach settlement in label-free detection lawsuit

Chalfont St.Giles, UK, August 13th, 2011 – GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today that a settlement has been reached with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) in an intellectual property lawsuit related to GE Healthcare Life Sciences’ technology for studying molecular interactions with Surface Plasmon Resonance (SPR). In 2010, GE Healthcare had filed suit in Germany for infringement of SPR related patents against Bio-Rad. GE Healthcare and Bio-Rad have now agreed to settle their dispute and withdraw their claims pursuant to a license granting Bio-Rad access to a collection of GE Healthcare patents.

The licensed patents relate to certain aspects of GE Healthcare Life Sciences’ unique technology and BiacoreTM instrument for SPR-based quantitative studies of molecular interactions. This non-exclusive license grants Bio-Rad rights with respect to using GE Healthcare’s proprietary technologies in Bio-Rad’s own SPR products.

“This license recognizes the considerable value that our R&D effort and surface plasmon resonance technology brings to life scientists” said Johan von Heijne, General Manager Research Products, GE Healthcare. “We are pleased that granting this license to Bio-Rad will enable scientists to expand the use of SPR for molecular interaction and binding studies even further in pharmaceutical drug discovery and development, and in basic life sciences research.”

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

For our latest news, please visit http://newsroom.gehealthcare.com

Contact

College Hill

Dr Lynne Trowbridge, Tim Watson, Dimithri Wignarajah

+44 (0)20 7866 7861

GE-Corporate@collegehill.com

SOURCE

More in Home